• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与 PSA 关系:新公式。

Obesity-PSA relationship: a new formula.

机构信息

Urology Department, Mansoura University, Mansoura, Egypt.

出版信息

Prostate Cancer Prostatic Dis. 2010 Jun;13(2):186-90. doi: 10.1038/pcan.2009.53. Epub 2009 Dec 22.

DOI:10.1038/pcan.2009.53
PMID:20029402
Abstract

To clinically apply the inverse PSA-body mass index (BMI) correlation and enhance PSA sensitivity in obese cases, a new formula is warranted. An innovated BMI-PSA equation is designed. PSA-BMI adjusted formula (named Hekal's equation): measured total PSA (ng ml(-1)) multiplied by age (years) and divided by BMI of the patient. The formula is applied over a randomly chosen 1000 cases of different PSA, BMI, age and trans-rectal ultrasound biopsy results, the yield of new PSA is correlated with pathology and age-specific PSA adjustment values. Among the 988 cases with complete data, obesity (BMI: 30-35 kg m(-2)) in 236 cases (23.8%) and 79 cases (7.9%) have BMI>35 kg m(-2). Mean PSA was 5.8 ng ml(-1) (s.d.+/-8.4 ng ml(-1)). Cases stratified based on their age (every 10 years). The new equation was applied. Obesity is detected in 33.5 and 43.6% of fifth and sixth decade of life respectively (P=0.02), with low measured PSA values (2.1, 3.8 ng ml(-1), respectively). By such PSA measurement biopsy may be omitted, missing 53.3% of malignant cases. In contrast, PSA adjusted were 4 and 9.3 ng ml(-1) within the same group of patients. With such values, the decision of a biopsy could not be missed for the targeted groups. Specificity and sensitivity of adjusted PSA values at cutoff point 4 ng ml(-1) was 41.7 and 70%, respectively. Based on our results, the new PSA-BMI adjusted formula is reproducible, easy applied formula. With such a formula the higher sensitivity of PSA in obese patients could be achieved. The misleading low PSA in obese cases in the fifth and sixth decade will be corrected.

摘要

为了将反 PSA-体重指数(BMI)相关性应用于临床并提高肥胖患者的 PSA 敏感性,需要一个新的公式。设计了一个创新的 BMI-PSA 方程。PSA-BMI 调整公式(命名为 Hekal 方程):测量的总 PSA(ng/ml)乘以年龄(岁),再除以患者的 BMI。该公式适用于随机选择的 1000 例不同 PSA、BMI、年龄和经直肠超声活检结果,新 PSA 的检出率与病理学和年龄特异性 PSA 调整值相关。在 988 例完整数据中,236 例(23.8%)和 79 例(7.9%)肥胖(BMI:30-35kg/m2),BMI>35kg/m2。平均 PSA 为 5.8ng/ml(标准差+/-8.4ng/ml)。根据年龄分层(每 10 年)。应用新方程。第五和第六个十年分别发现肥胖率为 33.5%和 43.6%(P=0.02),PSA 值较低(分别为 2.1、3.8ng/ml)。通过这种 PSA 测量,活检可能被省略,漏诊了 53.3%的恶性病例。相比之下,同一组患者的 PSA 调整值为 4 和 9.3ng/ml。有了这些值,就不会错过针对目标人群进行活检的决定。在截断点 4ng/ml 时,调整后的 PSA 值的特异性和敏感性分别为 41.7%和 70%。根据我们的结果,新的 PSA-BMI 调整公式是可复制的、易于应用的公式。通过这种公式,可以提高肥胖患者 PSA 的敏感性。第五和第六个十年肥胖患者 PSA 较低的误导性问题将得到纠正。

相似文献

1
Obesity-PSA relationship: a new formula.肥胖与 PSA 关系:新公式。
Prostate Cancer Prostatic Dis. 2010 Jun;13(2):186-90. doi: 10.1038/pcan.2009.53. Epub 2009 Dec 22.
2
Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.一项基于社区的研究:年龄和体重指数对新加坡华裔男性前列腺特异性抗原水平的影响
BJU Int. 2009 Jun;103(11):1487-91. doi: 10.1111/j.1464-410X.2008.08246.x. Epub 2008 Dec 8.
3
[Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].[北京50岁以上男性血清前列腺特异性抗原水平与体重指数的关系]
Zhonghua Yi Xue Za Zhi. 2009 Jun 23;89(24):1681-3.
4
The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.肥胖与较低血清前列腺特异性抗原水平对美国男性前列腺癌筛查结果的影响。
BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12.
5
The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis.肥胖与前列腺癌之间不确定的关系:一项义大利前列腺活检队列分析。
Eur J Surg Oncol. 2011 Dec;37(12):1025-9. doi: 10.1016/j.ejso.2011.09.036. Epub 2011 Oct 1.
6
The patients less than 50 years: is there a need to lower the PSA cutoff point?50岁以下的患者:是否需要降低前列腺特异抗原(PSA)的临界值?
Prostate Cancer Prostatic Dis. 2009;12(2):148-51. doi: 10.1038/pcan.2008.48. Epub 2008 Sep 30.
7
Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.在总前列腺特异性抗原水平为2至4纳克/毫升范围内的游离前列腺特异性抗原百分比,与4至10纳克/毫升范围内相比,并不会显著增加检测临床显著性前列腺癌所需的活检次数。
J Urol. 2002 Aug;168(2):504-8.
8
Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.前列腺癌筛查诊所参与者的体重指数、前列腺特异性抗原及直肠指检结果
Urology. 2008 May;71(5):787-91. doi: 10.1016/j.urology.2007.11.036. Epub 2008 Feb 11.
9
[The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].[前列腺特异性抗原在局限性前列腺腺癌诊断中的作用。奈良泌尿肿瘤研究组]
Hinyokika Kiyo. 1996 Oct;42(10):795-804.
10
Obesity and screening PSA levels among men undergoing an annual physical exam.接受年度体检男性中的肥胖与前列腺特异性抗原筛查水平
Prostate. 2008 Mar 1;68(4):373-80. doi: 10.1002/pros.20704.

引用本文的文献

1
Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.评估来自三个地理区域的前列腺癌病例和对照个体中与 PSA 水平相关的因素。
Sci Rep. 2022 Jan 7;12(1):55. doi: 10.1038/s41598-021-04116-8.
2
Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data.存在竞争风险时纵向数据与生存数据的联合建模及其在前列腺癌数据中的应用
Stat Modelling. 2021 Feb;21(1-2):72-94. doi: 10.1177/1471082X20944620. Epub 2020 Sep 25.
3
The Correlation between Body Mass Index and Routine Parameters in Men Over Fifty.
五十岁以上男性体重指数与常规参数之间的相关性
World J Mens Health. 2017 Dec;35(3):178-185. doi: 10.5534/wjmh.16032. Epub 2017 Sep 6.
4
Prostate-specific antigen rising in Iranian men in correlation with body mass index, fasting blood sugar and blood lipid profile.伊朗男性前列腺特异性抗原水平升高与体重指数、空腹血糖和血脂谱的相关性
J Nephropathol. 2016 Oct;5(4):134-138. doi: 10.15171/jnp.2016.25. Epub 2016 Aug 7.
5
Obesity affects the biopsy-mediated detection of prostate cancer, particularly high-grade prostate cancer: a dose-response meta-analysis of 29,464 patients.肥胖影响活检介导的前列腺癌检测,尤其是高级别前列腺癌:对29464例患者的剂量反应荟萃分析。
PLoS One. 2014 Sep 3;9(9):e106677. doi: 10.1371/journal.pone.0106677. eCollection 2014.
6
Clinical management of obese patients with cancer.癌症肥胖患者的临床管理。
Nat Rev Clin Oncol. 2013 Sep;10(9):519-33. doi: 10.1038/nrclinonc.2013.120. Epub 2013 Jul 16.
7
Obesity and prostate cancer: weighing the evidence.肥胖与前列腺癌:权衡证据。
Eur Urol. 2013 May;63(5):800-9. doi: 10.1016/j.eururo.2012.11.013. Epub 2012 Nov 15.
8
Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.克罗地亚老年男性前列腺癌:5-羟色胺基因多态性及雄激素剥夺疗法对骨质减少的影响——一项初步研究
Genet Test Mol Biomarkers. 2012 Jun;16(6):598-604. doi: 10.1089/gtmb.2011.0279. Epub 2012 Mar 15.
9
Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.肥胖与雄激素剥夺治疗后行根治性前列腺切除术的男性的去势抵抗性疾病和转移相关:来自 SEARCH 数据库的结果。
BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17.
10
Predictive value of digital rectal examination for prostate cancer detection is modified by obesity.数字直肠检查对前列腺癌检测的预测价值受肥胖影响。
Prostate Cancer Prostatic Dis. 2011 Dec;14(4):346-53. doi: 10.1038/pcan.2011.31. Epub 2011 Jul 5.